Crinetics Pharmaceuticals

Filed a patent for "somatostatin subtype receptor 3 (sstr3) agonists and uses thereof" on Fri, July 14, 2023

Filed a patent for "melanocortin subtype-2 receptor (mc2r) antagonist for the treatment of acth-dependent cushing's syndrome" on Wed, April 5, 2023

Filed a patent for "compositions and methods for the treatment of congenital adrenal hyperplasia" on Fri, May 19, 2023

Filed a patent for "compositions and methods for the treatment of congenital adrenal hyperplasia" on Tue, April 9, 2024

Filed a patent for "formulations of a somatostatin modulator" on Thu, December 5, 2024

Filed a patent for "process of making somatostatin modulators" on Fri, September 15, 2023

Filed a patent for "process of making somatostatin modulators" on Thu, November 14, 2024

Filed a patent for "compositions and methods for administering paltusotine to patients with hepatic impairment" on Tue, March 28, 2023

Filed a patent for "melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof" on Thu, September 12, 2024

Filed a patent for "somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof" on Tue, December 13, 2022

Filed a patent for "somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof" on Fri, November 10, 2023

Filed a patent for "somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof" on Thu, August 1, 2024

Filed a patent for "somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof" on Thu, August 1, 2024

Filed a patent for "neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereof" on Wed, November 23, 2022

Filed a patent for "neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereof" on Fri, October 6, 2023

Filed a patent for "neuropeptide y1 receptor (npy1r) targeted therapeutics and uses thereof" on Thu, July 11, 2024

Filed a patent for "crystalline melanocortin subtype-2 receptor (mc2r) antagonist" on Fri, December 16, 2022

Filed a patent for "crystalline melanocortin subtype-2 receptor (mc2r) antagonist" on Thu, June 27, 2024

Filed a patent for "parathyroid hormone (pth) receptor antagonists and uses thereof" on Thu, May 25, 2023

Filed a patent for "follicle-stimulating hormone receptor (fshr) targeted therapeutics and uses thereof" on Wed, October 5, 2022

Filed a patent for "melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof" on Tue, December 13, 2022

Filed a patent for "melanocortin type 2 receptor (mc2r) targeted therapeutics and uses thereof" on Thu, December 21, 2023

Filed a patent for "melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof" on Thu, April 4, 2024

Filed a patent for "non-peptide targeted therapeutics and uses thereof" on Mon, December 4, 2023

Filed a patent for "somatostatin modulators and uses thereof" on Thu, January 26, 2023